However, immunodepletion of c-Kit+ progenitors in TLR2 agonist-treated mice abrogates protection against tissue invasion during candidiasis, despite their similar amount of mature myeloid cells in the spleen at the moment of infection, than isotype control injected mice. The gene discussed is KIT; the disease is candidiasis.